Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2018-11-01
2019-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Affect-regulatory Characteristics of Deceptive Placebos
NCT05372744
Piloting MOL Intervention for Neuroleptic Decision Making
NCT03537040
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402
Mirtazapine Versus Placebo in Functional Dyspepsia
NCT01240096
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
NCT03828149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive Expectations Group
Participants receive a nasal spray that is in fact a placebo. However, they are told that it protects from experiencing negative emotions and generally improves their mood. They take the nasal spay in the laboratory and on seven consecutive days. Participants watch two film sequences that are supposed to induce sadness.
Placebo
Placebo nasal spray
Film Sequence
No-treatment control group
Participants do not receive the nasal spray. Participants watch two film sequences that are supposed to induce sadness.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Placebo nasal spray
Film Sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fluent in German language
Exclusion Criteria
* allergic to capsaicin
* allergic to sesame oil
* intake of psychopharmacological drugs
* intake of illegal drugs in the last two weeks
* consumption of alcohol in the last twelve hours
* students in medicine, pharmacy, or psychology
* completed studies in medicine, pharmacy or psychology
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philipps University Marburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Winfried Rief, Professor
Role: PRINCIPAL_INVESTIGATOR
Philipps-Univeristy of Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Philipps-Universität Marburg
Marburg, Deutschland, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-15k
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.